Amakhasimende ethu
*Amakhasimende asohlwini awaphikiswa lapho kudalulwa
Inkampani China Beijing Tongrentang Group Co., Ltd.
I-Tong Ren Tang yasungulwa ngo-1669. Ikhethekile emithini yendabuko yamaShayina okuhlanganisa imithi, ezempilo nokuphila kahle, ukunakekelwa kwezokwelapha okuphezulu, ukudayisa, njll. Inezitshalo zemithi ezingaphezu kuka-36 e-China ezikhiqiza imithi engaphezu kuka-2,600 nezithako zokudla, kanye nezitolo zezitolo ezingaphezu kuka-2,400 nezikhungo zezokwelapha. Isungule futhi emazweni nasezifundeni ezingama-28, okuhlanganisa i-USA, Canada, UK, Netherlands, Sweden, Switzerland, njll., amatheminali amaningi okuhlinzeka ngezinsizakalo zemithi yamaShayina kubantu bendawo. Ngo-2018, u-Tong Ren Tang wabhalisa imali engenayo engu-2.7 billion USD, kanye nempahla engaphezu kuka-4.1 billion USD.
I-China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
I-China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. inkampani enkulu ephethwe nguhulumeni esohlwini lwemithi, ebambe iqhaza kakhulu ocwaningweni nasekuthuthukiseni, ekukhiqizeni, ekuthengisweni nasezinsizeni zezempilo ezihlobene nemikhiqizo yezemithi. Ibhizinisi eliwumgogodla lika-CR Sanjiu lisemkhakheni wemikhiqizo yokunakekelwa kwezempilo ye-CHC kanye nemithi kadokotela, enezinhlobonhlobo eziningi zokufakwa kwemikhiqizo kanye nokunothisa okuqhubekayo kwemigqa yomkhiqizo nezinhlobonhlobo. Ibhizinisi le-CHC lokunakekelwa kwezempilo labathengi lihlanganisa cishe izigaba eziyi-10, okuhlanganisa umkhuhlane nomkhuhlane, isikhumba, amathumbu, ukukhwehlela, amathambo, izifo zezingane, izithasiselo zokudla, njll., kanye nemikhiqizo yalo eyinhloko inesabelo esikhulu semakethe; ibhizinisi layo lencwadi kadokotela lihlanganisa ukulwa nesimila, imithambo yenhliziyo nemithambo yobuchopho, amathumbu, ama-orthopaedic, ezingane kanye nezinye izindawo zokwelapha, futhi lijabulela idumela eliphezulu ngasohlangothini lwezokwelapha. Ngo-2022, imali engenayo ka-CR Sanjiu yayingu-2.58 billion USD.
I-Sunflower Pharmaceutical Group Co., Ltd.
I-Sunflower Pharmaceutical Group inezinkampani eziningi zamagatsha ezifana namabhizinisi akhiqiza imithi, izinkampani zemithi, izikhungo zocwaningo lwezemithi, izitshalo zokutshala amakhambi, njll. Imikhiqizo ihlanganisa imikhakha yezifo zezingane, izifo zabesifazane, uhlelo lokugaya ukudla, umkhuhlane wokuphefumula, isifo samathambo, isifo senhliziyo nemithambo yegazi ne-cerebrovascular, okuhlanganisa imithi yamaShayina ye-cerebrovascular, kuhlanganise nemithi yamaShayina. kanye nezithako zokudla. Phakathi kwazo, i-Pediatric Lung-Heat Cough & Asthma Oral Liquid/Particles iye yaqashelwa yi-China Non-prescription Medicines Association (CNMA) njengokuthi "No. 1 esigabeni somkhuhlane wezingane kanye nokukhwehlela kwemithi yobunikazi yaseShayina" iminyaka eminingi ilandelana. Ngo-2022, imali engenayo ye-Sunflower Pharmaceutical Group yafinyelela ku-720 million USD, kanti izigidi ezingu-500 zavela emithini yobunikazi yaseShayina.
Inkampani Livzon Pharmaceutical Group Inc.
I-Livzon Pharmaceutical Group Inc., eyasungulwa ngo-1985, iyinkampani ehlanganisa imithi ehlanganisa i-R&D yezemithi, ukukhiqiza nokudayisa enabasebenzi abangaphezu kuka-8,000. Iqembu njengamanje likhiqiza futhi lidayise izidakamizwa zamakhemikhali, imithi yobunikazi baseShayina, izidakamizwa zebhayoloji, kanye nama-in vitro diagnostic reagents emikhakheni yokugaya ukudla, inhliziyo nemithambo yobuchopho, i-endocrinology yokuzala, kanye nengqondo/imizwa. Ngo-2022, imali engenayo yeqembu yafinyelela ku-1.8 bhiliyoni we-USD, kanye nokutshalwa kwezimali kwezigidi ezingu-200 USD ku-R&D.
Izindleko zamasheya Dihon Pharmaceutical Group Co., Ltd.
I-Dihon Pharmaceutical Group Co., Ltd., eyasungulwa ngo-1993, manje isiyinkampani engaphansi kwe-Bayer. Iphakathi kwezinkampani eziphezulu eziyi-10 ze-OTC eChina. Umkhiqizo wawo oyinhloko iCompound Ketoconazole Ointment yezinkinga zesikhumba. Imali engenayo yonyaka ilinganiselwa ku-200 million USD.
Inkampani Golden Throat Holdings Group Limited
I-Golden Throat Holdings Group Company Limited, eyasungulwa ngo-1956, isibe ngomunye wabakhiqizi bemithi yobunikazi baseShayina Abaphezulu abangama-50 ngemva kweminyaka yokuthuthuka. Iqembu ligxile emikhakheni yemithi yobunikazi yamaShayina kanye nezithako zokudla, futhi manje selinemithi yobunikazi yamaShayina engaphezu kwama-60. Umkhiqizo obaluleke kakhulu iGolden Throat Lozenge uthunyelwe emazweni nasezifundeni ezingaphezu kuka-50 eNyakatho Melika, eYurophu, naseNingizimu-mpumalanga Asia. Ngo-2022, imali engenayo yeqembu yayingama-USD ayizigidi eziyi-140.
I-Yangtzi River Pharmaceutical Group
I-Yangztzi River Pharmaceutical Group, eyasungulwa ngo-1971, iyiqembu laseShayina elenza imithi elifakwe ohlwini loMnyango Wezesayensi Nobuchwepheshe njengelinye lamaBhizinisi okuqala e-Innovative of China futhi linabasebenzi abangaphezu kuka-16,000. Imikhiqizo ihlanganisa izidakamizwa zamakhemikhali, imithi yamaShayina enegunya lobunikazi, imikhiqizo yokunakekelwa kwezempilo ephelele, njll. Ngomzamo weqembu, izindinganiso zamazwe ngamazwe ezi-5 zemithi yokwelapha yaseShayina sezingenile ku-European Pharmacopoeia. Ngaphandle kweChina, imikhiqizo yayo isidayiselwe nakwamanye amazwe nezifunda ezingaphezu kuka-50. Ngo-2022, imali engenayo yomfula iYangtzi yayingaphezu kwezigidigidi eziyi-11 zama-USD.
I-Beihai Gofar Chuanshan Biological Co., Ltd.
I-Beihai Gofar Chuanshan Biological Co., Ltd. yasungulwa ngo-1993. Iyona kuphela inkampani esohlwini eyisipesheli samanzi olwandle pearl oyster (i-Hepu Southern Pearl/Hepu Akoya pearl), ulwelwe, ama-crustaceans nezinye izinsiza ezikhethekile zebhayoloji ukuthuthukiswa okudidiyelwe, ukucutshungulwa eChina. Ibhizinisi layo eliyinhloko ukukhiqizwa kwemithi, ukusatshalaliswa kwemithi, izinsizakalo zobuchwepheshe bezokwelapha kanye nokuxilongwa kwamangqamuzana nezimboni ze-forensic. Ngo-2022, imali engenayo ye-Gofar yayingama-USD ayizigidi ezingama-66.
I-Humanwell Healthcare (Group) Co., Ltd.
I-Humanwell Healthcare yasungulwa ngo-1993. Senze ubuholi noma isikhundla esiholayo ezingxenyeni zezidakamizwa zemizwa, izidakamizwa ze-steroid hormone, izidakamizwa zesizwe sama-Uyghur, njll. Isungule i-R&D yomhlaba wonke, ukubhaliswa, ukukhiqizwa nokudayiswa kwalo lonke uchungechunge lwenani lemithi, luthumela emazweni angama-70 nasezifundeni emhlabeni jikelele. Ngo-2022, imali engenayo ye-Humanwell Healthcare yayingu-3.2 billion USD.
I-SCIMYTH Pharmaceutical Group
I-SCIMYTH Pharmaceutical Group iyinkampani enkulu yeqembu enemithi njengento eyinhloko, ehlanganisa ukutshalwa kwemifino, ucwaningo lwezidakamizwa nokuthuthukiswa, ukumaketha kwezidakamizwa kanye nezinsizakalo zezokwelapha ezihlanganisa izingane, izifo zabesifazane, inhliziyo, ukuphefumula, i-oncology, izidakamizwa zezempilo kanye neminye imikhakha. Ngo-2022, imali engenayo yafinyelela ku-74 million USD. Ilinganiselwa ukuthi ibe nemali engenayo eyizigidi eziyizinkulungwane ezingama-700 ngo-2025.
Inkampani Shandong Hanfang Pharmaceutical Co., Ltd.
I-Shangdong Hanfang Pharmaceutical Co., Ltd., eyasungulwa ngo-2004, iyibhizinisi lesimanje lesimanje lemithi yendabuko yamaShayina elihlanganisa ucwaningo nentuthuko, ukukhiqiza nokudayisa. iyiqembu lemithi ehlukahlukene elithatha imboni yemithi yendabuko yamaShayina njengendima eholayo, futhi lihlanganisa ubuchwepheshe bezinto eziphilayo, izinsiza zezokwelapha, kanye nezimonyo ezithathwe emithini yendabuko yamaShayina.
I-Luoxin Pharmaceutical Group Stock Co., Ltd.
I-Luoxin Pharmaceutical Group Stock Co., Ltd., eyasungulwa ngo-1998, iyinhlangano yokunakekelwa kwezempilo eyenza ucwaningo lwezemithi nokuthuthukiswa, ukukhiqiza, ukuthengisa, kanye nenkonzo yokunakekelwa kwezempilo. Imali engenayo ye-Luoxin ngo-2022 yayiyizigidi ezingu-512 USD.
I-Guangdong Zhongsheng Pharmaceutical Co., Ltd.
I-Guangdong Zhongsheng Pharmaceutical Co., Ltd. yasungulwa ngo-1979. Ngokusekelwe emikhakheni yokwelapha yezifo zamehlo, inhliziyo nemithambo yegazi, ukuphefumula nokugaya ukudla, inkampani igxile ocwaningweni olusha lwezidakamizwa kanye nentuthuko ezindaweni ezikhethekile ezifana nomkhuhlane, i-steatohepatitis engeyona utshwala (NASH), izifo, i-ophthalmology kanye nokukhiqizwa kwayo. ibhizinisi core. Ibhizinisi eliyinhloko lale nkampani lihlanganisa i-R&D, ukukhiqizwa nokudayiswa kwemithi yobunikazi bendabuko yamaShayina, imithi yamakhemikhali, izinto zokwelapha zaseShayina nezingcezu zemithi yaseShayina, i-API yamakhemikhali, kanye nokutshalwa kwezimali ezimbonini ezihlobene ne-ophthalmology. Ngo-2022, imali engenayo yenkampani yayingama-USD ayizigidi ezingama-382.
I-Hunan Brilliance & Abundance Scientific Chinese Herbal Medicine Co., Ltd.
I-Hunan Brilliance & Abundance Scientific Chinese Herbal Medicine Co., Ltd., eyasungulwa ngo-2002, iyibhizinisi lesimanje lesimanje lezokwelapha elinomuthi wamaShayina we-ultra-micro decoction izingcezu njengomkhiqizo oyinhloko namalungiselelo emithi kanye nemithi yaseShayina ekhishwe njengamaphiko amabili.
Le nkampani Apeloa Pharmaceutical Co., Ltd.
I-Apeloa Pharmaceutical Co., Ltd., eyasungulwa ngo-1989, isisungule i-R&D yezemithi kanye namakhono okukhiqiza, yakha imikhakha yebhizinisi emithathu eyinhloko ye-API, CDMO, kanye ne-Finished Dosage Form (FDF). I-Apeloa isiphenduke inkampani yasekhaya ehamba phambili kuma-API akhethekile.
Njengomhlinzeki wesevisi omkhulu webhizinisi le-CDMO ochungechungeni lwemboni yezidakamizwa emisha, i-Apeloa yakhe ubudlelwano bokubambisana besikhathi eside nezinkampani ezinkulu zasekhaya nezangaphandle ezinkulu zekhemisi kanye ne-biotech, futhi yakha imikhiqizo yasekhaya eyaziwayo njenge-"Baishixin" kanye ne-"Tianliwei". Umuthi oyijenerikhi wokuqala we-Apeloa olawulwa okusezingeni eliphezulu usanda kwethulwa emakethe yase-US. Manje inabasebenzi abangaphezu kwe-1,000 ku-R&D. Ngo-2022, i-Apeloa yafinyelela imali engenayo engu-1.5 billion USD.
Inkampani Hunan Heng Chang Pharmaceutical Group Co., Ltd.
I-Hunan Heng Chang Pharmaceutical Group Co., Ltd., eyasungulwa ngo-2015, iyinhlangano ye-B2B yokusabalalisa imithi egxile ekuhlinzekeni amakhemisi amancane naphakathi nendawo, amakhemisi angawodwa kanye nezikhungo zokunakekelwa kwezempilo okuyisisekelo ezihlanganisa imikhakha ehlukahlukene njengemithi yobunikazi baseShayina, imithi yasentshonalanga, imithi yaseShayina yendabuko, imithi yezokwelapha kanye nemikhiqizo yokunakekelwa kwezempilo. Kuze kube manje, iQembu selisebenzise izinhlobo ezingaphezu kwezi-2,000, okuhlanganisa nemikhiqizo engaphezu kuka-1,600 ngaphansi komkhiqizo walo, futhi linamakhasimende angamalungu abhalisiwe angaphezu kuka-100,000, phakathi kwawo acishe abe ngu-50,000 angamakhasimende asebenzayo. Ngo-2022, imali engenayo ye-Heng Chang yayingama-USD ayizigidi eziyizinkulungwane ezingama-700.
I-Baotou Traditional Chinese Medicine Co., Ltd.
I-Baotou Traditional Chinese Medicine Co., Ltd., eyasungulwa ngo-1974, iyinkampani yesimanje ye-TCM ehlanganisa i-R&D, ukukhiqiza, ukuthengisa kanye nenkonzo. Imali engenayo ilinganiselwa ku-10 million USD.
Inkampani Kamp Medicine Co., Ltd.
I-Kamp Medicine Co., Ltd., eyasungulwa ku-1991, ingumkhiqizi wemithi oyingqayizivele ukhiqiza kokubili i-TCM nezidakamizwa zamakhemikhali eziphatha izifo zesistimu yokugaya, izifo zenhliziyo ne-cerebrovascular, izifo zesibindi nezinso, izifo ezilwa namagciwane, izithako ze-tonic nezomsoco, kanye nama-API nezinye izigaba.
I-Guangxi Santo Pharmaceutical Co., Ltd.
I-Guangxi Santo Pharmaceutical Co., Ltd., eyasungulwa ngo-1970, ikhethekile kwezokwelapha zaseZhuang. Imikhiqizo yayo kazwelonke ekhethekile i-"Jiubiying Stomachache Capsule", "I-Jiubiying Stomachache Tablet", "Xiao'er Xieshi Zhixie Powder", kanye nezinhlobonhlobo ezivikelwe zikazwelonke zemithi yendabuko yamaShayina, "i-Terminalia Throat Tablet", okuwumuthi wokuqala wokwelapha i-pharyngitis engapheli kanye ne-tonsillitis engapheli e-China. Iwine i- "Baihua Award" neminye imiklomelo eGuangxi. Ngo-2021, imali engenayo ye-Santo yayingu-25.7 million USD.
I-Hunan Kangshou Pharmaceutical Co., Ltd.
I-Hunan Kangshou Pharmaceutical Co., Ltd., eyasungulwa ngo-2003, inezimvume zemithi engu-52 ezihlanganisa nezinhlobo ezingu-8 ezikhethekile zemithi yendabuko yamaShayina, njengama-Shengxuebao granules, ama-Weixiangning granules, ama-Maxing Xuanfei granules, isiraphu ye-Yinchen Wuling, i-Guilu Yishen onsule liquid Izinhlamvu ze-Jiangzhuo, njll.
I-Jiangxi Juwang Pharmaceutical Industry Co., Ltd.
I-Jiangxi Juwang Pharmaceutical Industry Co., Ltd., eyasungulwa ngo-1969, ingumkhiqizi wemithi okhethekile emikhiqizweni yesifo senhliziyo, izifo zabesifazane kanye nezithasiselo zokudla zokulawula ushukela wegazi. Ngo-2021, imali engenayo ye-Juwang yayingama-USD ayizigidi eziyi-17.
I-Beijing Tcmages Pharmaceutical Co., Ltd.
I-Beijing Tcmages Pharmaceutical Co., Ltd. ibikhethekile ocwaningweni nasekukhiqizeni amagranule efomula ye-TCM iminyaka engaphezu kwengu-20 nesabelo sayo semakethe phakathi kwamathathu aphezulu e-China, kanye nemikhiqizo yayo nezinsizakalo ezweni lonke ezihlanganisa izibhedlela ezingaphezu kuka-3,000, futhi imikhiqizo isidayiselwe amazwe angaphezu kuka-20 nezifunda eNyakatho Melika, i-Europe, i-Australia yezigidi ezingu-232c, i-202c yezigidigidi ze-T7, njll. I-USD.
Inkampani engu-Guizhou Ruihe Pharmaceutical Co., Ltd.
I-Guizhou Ruihe Pharmaceutical Co., Ltd., eyasungulwa ngo-1998, ihlanganisa i-R&D, ukukhiqiza nokudayiswa kwe-TCM kanye nezidakamizwa zamakhemikhali ezimboza imijovo yamandla amancane, ama-granules, amaphilisi, amaphilisi, impushana, njll. Phakathi kwazo, umuthi okhethekile wokwelapha isifo sesibindi, "Shuganning Injection", umkhiqizo wawo ophambili.
I-Anhui CR Jinchan Pharmaceutical Co., Ltd. (Ngeye-China Resources Sanjiu)
I-Anhui CR Jinchan Pharmaceutical Co., Ltd. ingesinye sezisekelo ezine eziyinhloko zokukhiqiza ze-China Resources Sanjiu Group, ephethe imisebenzi yokukhiqiza imikhiqizo emibili eyinhloko ye-China Resources Sanjiu, okuyimithi elwa nesimila kanye nezinhlayiyana zemithi yamaShayina. Uchungechunge lwe-Cinobufotalin luwuhlobo kazwelonke lwemithi yaseShayina evikelekile eyimfihlo, okuwukukhiqizwa kokuqala nokukhethekile e-China; izinhlayiya zayo zefomula ye-TCM ziphakathi kwemikhiqizo yokuqala yokuhlola egunyazwe uhulumeni, futhi eyokuqala ukubona ukukhiqizwa okuhlakaniphile e-China.
Inkampani Kangmei Pharmaceutical Co., Ltd.
I-Kangmei Pharmaceutical Co., Ltd., eyasungulwa ngo-1997, ibhizinisi layo lidlula phezulu, maphakathi, phansi nomfula embonini yemithi yendabuko kusukela ekulinyweni kwemifino, ukuhweba kuya ekukhiqizeni nasekuthuthukisweni nasekuthengiseni. Njengamanje, inkampani inamabhizinisi acishe abe yi-100 ezweni lonke ahlanganisa ibhizinisi lokutshalwa kwemifino, imakethe yokuhweba ngamakhambi, isikhungo sesimanje sezinto ezisetshenziswayo kanye nezizinda zezimboni, yakhe izisekelo zokukhiqiza eziyi-11 zesimanje zezingcezu nemithi ye-TCM, futhi ilawula ngaphezu kuka-60% wohwebo lwezwe lwemakethe yamakhambi. Ngo-2022, imali engenayo ye-Kangmei yayingu-597 million USD.
I-Hunan Tianjicaotang Pharmaceutical Co., Ltd.
I-Hunan Tianjicaotang Pharmaceutical Co., Ltd. yinkampani ehlanganisa ucwaningo lwezemithi nokuthuthukiswa, ukutshalwa kwemifino, ukukhiqizwa kwemithi kanye nokudayisa. Uchungechunge oluyinhloko lwemikhiqizo yenkampani: ukususa ukushisa nokukhipha ubuthi (i-Qingre Sanjie capsule, i-Yanning capsule, i-Chuanwang Xiaoyan capsule, njll.); I-cardiovascular and cerebrovascular (amaphilisi e-Naodesheng, amaphilisi e-breviscapine, njll.); Imikhiqizo yomchamo (inhlanganisela ye-Shilontong capsule, i-compound Shiwei capsule, njll.).
I-Jiangxi Kingstone Unite Pharmaceutical Co., Ltd.
I-Jiangxi Kingstone Unite Pharmaceutical Co., Ltd., eyasungulwa ngo-1978, iyinkampani eyenza imithi ehlanganisa ukutshalwa kwemifino, i-R&D, ukukhiqizwa nokudayisa. Imikhiqizo isetshenziswa kakhulu kwezokwelapha zezingane, izifo zabesifazane, kanye nemithi yokuqeda umkhuhlane nomkhuhlane.
Isibhedlela iShuguang Sixhunywe ne-Shanghai Chinese Medicine University
Isibhedlela i-Shuguang Esixhunywe ne-Shanghai Chinese Medicine University yisibhedlela esineminyaka eyikhulu ubudala se-Class-A seBanga lesi-3 (izinga eliphezulu e-China) se-Chinese Medicine e-Shanghai. Ingesinye sezibhedlela ezijwayelekile eziyi-10 zaseShanghai, kanye nesibhedlela sikazwelonke esikhombisa imithi yendabuko yamaShayina. Isibhedlela sinikeza imibhede ebhalisiwe engu-1,200. Inezici ezihlukile Zomuthi WaseShayina futhi inezinzuzo ezivelele. Inemikhakha emi-3 eyisihluthulelo yoMnyango Wezemfundo: I-Orthopedics and Traumatology ye-TCM, Imithi Yangaphakathi Ye-TCM, kanye Nekhemisi YaseShayina (Ukulungiswa Kwemithi YaseShayina kanye Ne-Clinical Pharmacology ye-TCM), iziyalo eziyisi-9 ezibalulekile Zokuphathwa Kwemithi Yendabuko YaseShayina, 6 amakhono abalulekile emitholampilo yeKhomishini Yezempilo Kazwelonke, amakhono abalulekile ayi-14. Umnyango Wezimo Eziphuthumayo we-TCM uyisisekelo esiphuthumayo Sokuphathwa Kukazwelonke Kwemithi Yendabuko YamaShayina, Igumbi Lokulungiselela liyisisekelo sikazwelonke sokulungiswa kwemithi yendabuko yamaShayina kanye nokuguqulwa kwemithamo, futhi uMnyango Wezokusebenza Kwezinzwa uyisisekelo sokuvimbela isifo sohlangothi kanye nokwelashwa kweKhomishini Yezempilo Kazwelonke.
Isifundazwe sase-Hunan Esixhumene Ngokuqondile nesibhedlela i-TCM
Isibhedlela saseHunan Esixhumene Ngokuqondile Nesibhedlela i-TCM, esasungulwa ngo-1954, siyisibhedlela esijwayelekile se-Class-A seBanga lesi-3 sezokwelapha zaseShayina, kanye nesibhedlela sikazwelonke se-Top 100 Chinese Medicine. Inabasebenzi abangu-2,054, nemibhede engu-1,800 etholakalayo. I-acupuncture kanye ne-Moxibustion, I-Hepatology, Izifo Zamaphaphu, I-Oncology, kanye ne-Clinical Pharmacy yizici ezibalulekile ze-TCM Zokuphathwa Kukazwelonke Kwemithi Yendabuko YamaShayina. Amandla odokotela bomchamo, i-neurosurgery, ukuhlinzwa okujwayelekile, i-bariatric surgery, imithi yezimo eziphuthumayo, eyokubelethisa kanye ne-gynecology aphakathi kwezihamba phambili esifundazweni.
Isibhedlela sokuqala saseHunan University of Chinese Medicine
Isibhedlela Sokuqala sase-Hunan University of Chinese Medicine, esasungulwa ngo-1963, siyisisekelo socwaningo lwezokwelapha lwe-TCM kanye nesikhungo sikazwelonke semitholampilo yokufundisa nokuqeqeshwa kwe-TCM. Inendawo yokwakhiwa ephelele engamamitha-skwele ayi-610,000 kanye nemibhede ebhalisiwe eyi-1,800. Ithola iziguli ezingaphezu kwezigidi eziyi-1.6 kanye neziguli ezilaliswayo ezicishe zibe ngu-70,000 ngonyaka.
Isibhedlela Sesibili se-Xiangya saseCentral South University
I-Second Xiangya Hospital of Central South University, eyasungulwa ngo-1958, ifaka inombolo ye-13 ngamandla aphelele ezibhedlela zaseShayina. Inemikhakha engu-23 ebalulekile yomtholampilo kazwelonke. Ubuchwepheshe bayo obufana ne-Psychiatry, i-metabolic endocrinology, ukuhlinzwa kwenhliziyo, i-dermatology kanye nezifo ze-venereal, i-geriatrics, i-nephrology, ikhemisi yomtholampilo, ukufakelwa kwezitho zomzimba, nokunye okukhethekile kuphakathi kokuhamba phambili ezweni. Yake yathola iziguli ezingalaliswanga eziyizigidi ezingu-3.948 kanye nokuvakashelwa izimo eziphuthumayo, yakhulula iziguli ezilaliswayo ezingu-186,000, futhi yahlinza abantu abangu-146,000 ngonyaka njengecala eliphakeme kakhulu. Eminyakeni yamuva nje, uye wabamba iqhaza ekuhlelweni kwezempilo kwezimo eziphuthumayo ezinkulu zasekhaya izikhathi eziningi. Ngesikhathi sokuvikela nokulawula i-COVID-19, bangaphezu kuka-600 abantu abathunyelwe eWuhan, Beijing, Xinjiang, West Africa nakwezinye izindawo ukulwa nalolu bhubhane, abalwe phakathi kwabaphambili eChina.
Isibhedlela Sesibili saseHunan University of Chinese Medicine (Hunan Chinese Medicine Hospital)
Yasungulwa ngo-1934, iSibhedlela Sesibili sase-Hunan University of Chinese Medicine, esaziwa nangokuthi i-Hunan Chinese Medicine Hospital, siyisibhedlela esiyinhloko sesifundazwe se-Class-A Grade-3 semithi yamaShayina. Manje inabasebenzi abangaphezu kuka-1,200, imibhede engu-1,156 etholakalayo, iminyango engu-51 yomtholampilo nobuchwepheshe bezokwelapha; 4 amakhono abalulekile kazwelonke: Proctology, Dermatology, Orthopaedics, Gynecology; Iziyalo eziyinhloko ze-3 zokuphathwa kweNational Administration of Traditional Chinese Medicine: I-TCM dermatology, i-TCM Proctology, ukuvuselelwa kwe-TCM; I-9 amakhono abalulekile we-National Administration of Traditional Medicine yaseShayina: I-Proctology, i-Dermatology, i-Orthopaedics, i-Gynecology, i-Encephalopathy, imithi yenhliziyo, izifo ze-spleen nesisu, i-Otolaryngology, Ukuvimbela kanye nokunakekelwa Kwezempilo kwe-TCM.
I-Orthopediki Yemithi Yendabuko YaseShayina iZhuzhou City
I-Orthopaedics of Traditional Chinese Medicine i-Zhuzhou City, eyasungulwa ngo-1958, enobuchwepheshe bendabuko bokusethwa kwamathambo "Shi's" kanye nokwelashwa kwemithi njengefa layo lezemfundo, iyisibhedlela esikhethekile sokulimala kwamathambo e-Class-A Grade-3. Ikleliswe endaweni engu-62 phakathi kwesibhedlela esiphezulu se-TCM esiyi-100 kuzinzuzo zesici se-TCM kanye nomthelela wezobuchwepheshe ngo-2020.